Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus's egg?

BMC Veterinary Research

Volumn 8, Issue , 2012, Pages

  Muijsers, Mariska ^a   Martel, An ^a   Van Rooij, Pascale ^a   Baert, Kris ^b   Vercauteren, Griet ^a   Ducatelle, Richard ^a   De Backer, Patrick ^a   Vercammen, Francis ^c   Haesebrouck, Freddy ^a   Pasmans, Frank ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Medicem NV   (Belgium)

^c CENTRE FOR RESEARCH AND CONSERVATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALYTES MULETENSIS; AMPHIBIA; ANIMALIA; BATRACHOCHYTRIUM DENDROBATIDIS; DISCOGLOSSUS PICTUS SCOVAZZI;

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

AMPHIBIA; ANIMAL; ARTICLE; BODY WEIGHT; CHYTRIDIOMYCETES; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; LARVA; MICROBIAL SENSITIVITY TEST;

AMPHIBIANS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BODY WEIGHT; CHYTRIDIOMYCOTA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; LARVA; MICROBIAL SENSITIVITY TESTS;

EID: 84866545690     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-8-175     Document Type: Article

References (26)

1. Berger L, Speare R, Daszak P, Green DE, Cunningham AA, Coggin CL, Slocombe R, Ragan MA, Hyatt AD, McDonald KR, Hines HB, Lips KR, Marantelli G, Parkess H. Chytridiomycosis causes amphibian mortality associated with population declines in the rain forests of Australia and Central America. Proc Natl Acad Sci USA 1998, 95:9031-9036. 10.1073/pnas.95.15.9031, 21197, 9671799.
2. Skeratt LF, Berger L, Speare R, Cashins S, McDonald LR, et al. Spread of chytridiomycosis has caused the rapid global decline and extinction of frogs. EcoHealth 2007, 4:125-134.
3. Longcore JE, Pessier AP, Nichols DK. Batrachochytrium dendrobatidis gen. et sp. nov., a chytrid pathogenic to amphibians. Mycologia 1999, 91(2):219-227.
4. Voyles J, Berger L, Young S, Speare R, Webb R, Warner J, Rudd D, Campbell R, Skerratt LF. Electrolyte depletion and osmotic imbalance in amphibians with chytridiomycosis. Dis Aquat Org 2007, 77:113-118.
5. Voyles J, Young S, Berger L, Campbell C, Voyles WF, Dinudom A, Cook D, Webb R, Alford RA, Skeratt LF, Speare R. Pathogenesis of chytridiomycosis a cause of catastrophic Amphibian declines. Science 2009, 326:582-585. 10.1126/science.1176765, 19900897.
6. Berger L, Speare R, Pessier A, Voyles J, Skerratt LF. Treatment of chytridiomycosis requires urgent clinical trials. Dis Aquat Org 2010, 92:165-174. 10.3354/dao02238, 21268978.
7. Berger L, Speare R, Maranetelli G, Skerratt LF. A zoospore inhibition technique to evaluate the activity of antifungal compounds against Batrachochytrium dendrobatidis and unsuccessful treatment of experimentally infected green tree frog (Litorea caerulea) by fluconazole and benzalkonium chloride. Res Vet Sci 2009, 87(1):106-110. 10.1016/j.rvsc.2008.11.005, 19117582.
8. Martel A, van Rooij P, Vercauteren G, Baert K, van Waeyenberghe L, de Backer P, Garner T, Ducatelle R, Haesebrouck F, Pasmans F. Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians. Medical Mycology 2011, 49(2):143-149. 10.3109/13693786.2010.508185, 20718611.
9. Fisher MC, Garner TWJ, Walker SF. Global emergence of Batrachochytrium dendrobatidis and amphibian chytridiomycosis in space, time and host. Annu Rev Microbiol 2009, 63:291-310. 10.1146/annurev.micro.091208.073435, 19575560.
10. Garner TWJ, Garcia G, Carroll B, Fisher MC. Using itraconazole to clear Batrachochytrium dendrobatidis infection and subsequent depigmentation of Alytes muletensis tadpoles. Dis Aquat Org 2009, 83:257-260.
11. Parker JM, Mikaelian I, Hahn N, Diggs HE. Clinical diagnosis and treatment of epidermal chytridiomycosis in African Clawed frogs (Xenopus tropicalis). Comp Med 2002, 52(3):265-268.
12. Hohreiter DW, Rigg DK. Derivation of ambient water quality criteria for formaldehyde. Chemosphere 2001, 45:471-486. 10.1016/S0045-6535(01)00061-3, 11680743.
13. Bishop PJ, Speare R, Poulter R, Butler M, Speare BJ, Hyatt A, Olsen V, Haigh A. Elimination of the amphibian chytrid fungus Batrachochytrium dendrobatidis by Archey's frog Leiopelma archeyi. Dis Aquat Org 2009, 84:9-15.
14. Rosenthal RL, Blackman A. Bone-marrow hypoplasia following use of chloramphenicol eye drops. J Am Med Assoc 1965, 191(2):136-137.
15. El-Mofty M, Abdelmeguid N, Sadek I, Essawy A, Abdel-Aleem E. Induction of leukemia in chloramphenicol-treated toads. East Mediterr Health J 2000, 6:1026-1034.
16. Pasmans F, Baert K, Martel A, Bousquet-Melou A, Lanckriet R, De Boever S, Van Immerseel F, Eeckhaut V, De Backer P, Haesebrouck F. Induction of the carrier state in pigeons infected with Salmonella enterica subspecies enterica serovar typhimurium PT99 by treatment with florfenicol: a matter of pharmacokinetics. Antimicrob Agents Chemother 2008, 52(3):954-961. 10.1128/AAC.00575-07, 2258533, 18180355.
17. Boyle DG, Boyle DB, Olsen V, Morgan JAT, Hyatt AD. Rapid quantitative detection of chytridiomycosis (Batrachochytrium dendrobatidis) in amphibian samples using real-time Taqman PCR assay. Dis Aquat Org 2004, 60:141-148.
18. Waterworth PM. Effect of minocycline on candida albicans. J Clin Pathol 1974, 27(4):269-272. 10.1136/jcp.27.4.269, 478100, 4212409.
19. Nicholls MWN. Polymyxin sensitivity of Candida tropicalis. J Med Microbiol 1970, 3:529-538. 10.1099/00222615-3-3-529, 4319621.
20. Lau H, Ballal V, Shenoy S, Acharya SR. Evaluation of antifungal efficacy of 5% doxycyline hydrochloride, 2.5% sodium hypochlorite, 17% ethylenediamine tetraacetic acid and 0.2% chlorhexidine gluconate against Candida albicans. An in vitro study. Endotontology 2008, 20:6-13.
21. Day S, Lalitha P, Haug S, Fothergill AW, Cevallos V, Vijayakumar R, Prajna NV, Acharya NR, McLeod SD, Lietman TM. Activity of antibiotics against Fusarium and Aspergillus. Br J Ophtalmol 2009, 93:116-119.
22. Bushby SRM, Hitchings GH. Trimethoprim, a sulphonamide potentiator. Brit J Pharmacol 1968, 33(1):72-90. 1570262, 5301731.
23. Bohni E. Chemotherapeutic activity of the combination of trimethoprim and sulfamethoxazole in infections of mice. Postgrad Med J 1969, 45(suppl):18-21.
24. Van Duijkeren E, Van Klingeren B, Vanoldruitenborghoosterbaan MMS, Breukink HJ, Vanniert ASJPAM, Vulto AG. In vitro susceptibility of equine salmonella strains to trimethorpim and sulfonamide alone or in combination. Am J Vet Res 1994, 55(10):1386-1390.
25. Trapanier LA. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J of Vet Pharmacol Therap 2004, 27(3):129-138.
26. Tjalve H. Adverse reactions to veterinary drugs reported in Sweden during 1991-1995. J vet Pharmacol Therap 1997, 20:105-110.